$26.45+0.21 (+0.80%)
At close: Nov 16, 2026, 4:00 PM ET· Nasdaq · USD
Data under review since Nov 13, 2026, showing figures confirmed Nov 12, 2026.Under review: these figures were confirmed on an earlier night and are shown while our checks are re-run.
Zymeworks BC (ZYME) Stock
Zymeworks BC (ZYME) closed at $26.45 on Nov 16, 2026.
Sources Company filings, market prices and computed by Tenet Filings, prices and TenetHow we compute thisNot investment advice
Key stats
- Previous close
- $26.45
- Nov 16, 2026
Industry: Drugs
Zymeworks BC Inc isn't scored yet Not enough ingested fundamentals to compute a Tenet Score for this stock.
Tenet Score
Not scored. We do not hold normalized financials for this listing, so the Tenet value screens do not apply. That is usually a foreign-domiciled ADR or a very new listing. Its price, chart, and news below are its own.
Price
Loading chart…
P/E
—
no P/E on file
P/B
—
no P/B on file
P/S
—
no P/S on file
ROE
—
no ROE for this year, and Tenet does not compute one yet
Operating margin
—
no operating margin on file
Net margin
—
no net margin on file
Current ratio
—
no current ratio on file
Net debt / EBITDA
—
no leverage ratio on file
EPS CAGR 5y
—
needs five years of positive earnings
Market cap
—
no market cap on file
Div yield
—
no yield on file
52-wk range
—
no 52-week range on file
The rest of this report
Which sections of this report have data for this listing, and a live peek at each.
About Zymeworks BC Inc
Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Ph…
Not investment advice.




